Friday

5th Jun 2020

Coronavirus

Will coronavirus change EU's pharma supply chain?

  • The French National Pharmaceutical Academy estimates that the EU imports 80 percent of its 'active pharmaceutical ingredients' - mostly from China and India (Photo: Grumpy-Puddin)

The impact of the coronavirus on China and India, two of the world's largest pharmaceutical exporters, has disrupted medicine supply chains worldwide, seeing manufacturing, distribution and trade restrictions, plus short-term scarcities for certain products.

"This crisis has revealed our morbid dependency on China and India as regards pharmaceuticals," the European Commission vice-president Vera Jourova said on Sunday (April 19) in a debate on Czech state television.

Read and decide

Join EUobserver today

Support quality EU news

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

"This is something that makes us vulnerable and we have to make a radical change there," she added, stressing that "this is a big lesson we have learnt".

While many countries depend on China for supplies of masks, tests kits and other antivirus gear, India remains the world's top export of so-called 'generics', such as paracetamol and the anti-malarial drug hydroxychloroquine which is being tested as a possible treatment for Covid-19.

The global race for hydroxychloroquine forced India to put restrictions on its pharmaceutical exports in March, but the country rapidly changed its position amid pressure from the US.

According to Jourová, the commission will reassess the EU's pharmaceutical supply chains and try to diversify them to produce within the bloc as many supplies as possible.

This action plan will then be put to MEPs and member states.

France and some other EU countries have already urged more manufacturing "sovereignty" from foreign supplies in strategic value chains.

"There will be a 'before' and an 'after' the coronavirus in global economics," warned French finance minister Bruno Le Maire last month.

'Isolationism' risks

The European Commission recently published guidelines for member states on the optimisation of supply of medicines and stockpiling, linked to the Covid-19 pandemic, and urged member states to lift exports bans.

However, some export restrictions of medical supplies remain across the bloc, in member states such as Hungary or Belgium.

Some experts have warned of the negative consequences of these measures, stressing the pharmaceutical supply chain is intended to work across borders.

"The consequences of export bans are directly detrimental to the availability of medicines for patients across the EU and globally, as well as risking retaliatory measures from other regions that could impact timely availability of medicines for European patients," the European Federation of Pharmaceutical Industries and Associations (EFPIA) said in a statement.

"No one country can meet all its needs on its own, and through restrictions, countries risk isolating themselves and their citizens from the global supply network," they added.

Additionally, the EFPIA called on the commission to ensure that member states should not take unilateral decisions that could negatively impact on the supply of essential new vaccines, diagnostics and treatments.

'Profiteering'

Meanwhile, a group of 20 NGOs and academics in the UK have voiced concerns about the risk of pharmaceutical companies profiteering off the pandemic or creating barriers for researchers attempting to build up new knowledge.

"There is a real danger that without safeguards, pharmaceutical companies may gain exclusive rights to a new vaccine, which in turn could lead to price gouging and unaffordable prices for millions of people," write the authors in an open letter.

The upcoming EU pharmaceutical strategy, which will be unveiled by the commission at the end of 2020, is expected to reflect the experiences linked to the coronavirus pandemic and propose specific actions to secure supplies and ensure innovation for patients.

As a part of the new industrial strategy announced last March, the new pharmaceutical roadmap also aims to address pharmaceutical pricing, as well making the sector more environment-friendly.

Column

Saving Europe from corona's nasty geopolitics

Four months into the corona crisis and one month into the social and economic shutdown, it seems the big geopolitical loser of the pandemic is likely going to be Europe.

Opinion

The plight of Europe's disabled under coronavirus

'As a single mother, I am now caring for my severely disabled son alone, 24/7, without any assistance, without rest, with more demand for shopping, cooking, feeding and intensive care.'

Opinion

Nobody's fault? Europe's sleepwalk into disaster

By March, the emergency had forced every government in Europe into an impossible choice - letting many people die and health systems collapse, or ground much of public life and inflict massive harm on their economic lives.

News in Brief

  1. Poland accused of 'blatant violation' of EU court injunction
  2. EU concerned by US approach to Kosovo and Serbia
  3. City morgues cast doubt on Putin's virus data
  4. ECB increases pandemic stimulus to €1.35 trillion
  5. New EU cloud computing platform 'moonshot'
  6. City of Berlin passes anti-discrimination law
  7. Iran hits record corona cases in second wave
  8. EU job losses tell tale of pandemic damage

Feature

Why developing countries may be last to get the vaccine

'The current standard for vaccines is to be kept at two to eight degrees and that is really tough in many developing countries when it can be up to 50 degrees outside,' warn experts on the challenges facing low-income countries.

Stakeholders' Highlights

  1. UNESDAHow reducing sugar and calories in soft drinks makes the healthier choice the easy choice
  2. Nordic Council of MinistersGreen energy to power Nordic start after Covid-19
  3. European Sustainable Energy WeekThis year’s EU Sustainable Energy Week (EUSEW) will be held digitally!
  4. Nordic Council of MinistersNordic states are fighting to protect gender equality during corona crisis
  5. UNESDACircularity works, let’s all give it a chance
  6. Nordic Council of MinistersNordic ministers call for post-corona synergies between economic recovery and green transition

Latest News

  1. After Covid-19, deserted Venice struggles for survival
  2. Commission plans strategy to 'maximise' vaccine access
  3. How spies use women to steal EU secrets
  4. Hong Kong - when the Chinese Dream became a nightmare
  5. Right of reply: Letter from the Hungarian government
  6. Kosovo to restart EU/US-led Serbia talks
  7. EU Commission slammed for Covid-19 'mid-threat' ranking
  8. EU Commission seeks help as hundreds stuck off Malta coast

Join EUobserver

Support quality EU news

Join us